A practical provider guide to helping patients access Auvi-Q. Steps for prescribing, navigating insurance, using ASPN Pharmacies, and managing alternatives.
You've prescribed Auvi-Q for a patient with anaphylaxis risk. A week later, they call your office: "My pharmacy says they don't carry it. What do I do?"
This scenario plays out daily in allergy practices, pediatric offices, and primary care clinics across the country. Auvi-Q is not in shortage, but its unique distribution model means patients (and sometimes staff) don't know how to access it.
This guide provides a practical, step-by-step approach to helping your patients find and obtain Auvi-Q efficiently.
As of 2026, Auvi-Q has consistent supply from its manufacturer, Kaléo. Unlike EpiPen and its generics — which have faced recurring shortages since 2018 — Auvi-Q uses an independent manufacturing process and a specialty distribution network.
However, Auvi-Q is not stocked at most retail pharmacies. It is available through two primary channels:
This means a standard prescription sent to CVS, Rite Aid, or an independent pharmacy will likely not be filled as Auvi-Q. Understanding this distribution model is the first step to helping your patients.
When patients report difficulty obtaining Auvi-Q, the root cause is usually one of these issues:
If the prescription is sent to a pharmacy that doesn't stock Auvi-Q, the patient will be told it's "unavailable" or "out of stock" — which can be mistaken for a shortage. Auvi-Q prescriptions should be directed to ASPN Pharmacies or Walgreens.
Prescriptions written generically for "epinephrine auto-injector" will be filled with EpiPen or its authorized generic by default. Auvi-Q requires a brand-name prescription, ideally marked as "Dispense As Written" (DAW).
Some insurance plans place Auvi-Q on a non-preferred tier, require prior authorization, or mandate step therapy. Patients may assume the medication is unavailable when the real issue is insurance approval.
Patients accustomed to picking up medications at their local pharmacy may not realize that Auvi-Q uses a home delivery model. Clear communication about the process — ideally at the point of prescribing — prevents confusion.
Write the prescription specifically for Auvi-Q (not generic epinephrine auto-injector). Mark it as DAW if your system requires it. This ensures the pharmacy dispenses the correct product.
The most reliable fulfillment pathway is through ASPN Pharmacies. You can send prescriptions via:
Consider registering for the ASPN Prescriber Portal, which allows you to track prescription status, complete refills, and manage patient records electronically.
If prior authorization is required, document the clinical rationale for Auvi-Q specifically. Helpful justifications include:
Cost is often the final barrier. Proactively connect patients with Kaléo's programs:
Having enrollment information readily available in your office — ideally integrated into your prescribing workflow — reduces patient drop-off between prescription and fill.
Empower patients to check availability themselves. Recommend:
When Auvi-Q is not appropriate for a specific patient (insurance restrictions, patient preference, etc.), alternatives include:
When switching devices, ensure the patient receives training on the new device's injection technique. Each product has distinct steps, and familiarity reduces errors during emergencies. For patient-facing information on alternatives, share our article on alternatives to Auvi-Q.
Add Auvi-Q to your frequently prescribed medications list and set ASPN Pharmacies as a default pharmacy option. This reduces friction during prescribing.
Ensure your staff knows that Auvi-Q uses a different distribution channel than most medications. When patients call asking about their Auvi-Q prescription, staff should be able to explain the ASPN Pharmacies process and provide the helpline number (1-877-30-AUVIQ).
Auvi-Q trainer devices (no needle, no medication) are available at no cost. Keep them in your office for patient and caregiver education. Hands-on training with the actual device design improves confidence and correct use during emergencies.
Epinephrine auto-injectors typically expire within 12–18 months. Consider implementing a reminder system to prompt refills before expiration — especially important for pediatric patients heading into allergy season or back-to-school periods.
Medfinder for Providers gives your team real-time visibility into which pharmacies have Auvi-Q (and other epinephrine products) in stock, helping you guide patients to the right location.
Auvi-Q's unique distribution model requires a small adjustment to prescribing workflows, but the payoff is access to a reliable, in-stock epinephrine auto-injector with features that improve patient usability. By routing prescriptions through ASPN Pharmacies, helping with insurance navigation, and connecting patients to financial assistance, you can ensure your anaphylaxis-risk patients maintain uninterrupted access to this life-saving medication.
For more information on the current shortage landscape, read our provider shortage briefing. For patient education resources, share our guides on finding Auvi-Q in stock and saving money on Auvi-Q.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
